Polyphenol Metabolite Pyrogallol-
Animals
Cell Line
Diabetes Mellitus, Experimental
/ metabolism
Diabetic Retinopathy
/ metabolism
Eye Proteins
/ metabolism
Humans
Inflammation
/ metabolism
Male
Mice
Mice, Inbred C57BL
Microglia
/ drug effects
Neovascularization, Pathologic
/ metabolism
Nerve Growth Factors
/ metabolism
Polyphenols
/ pharmacology
Pyrogallol
/ pharmacology
Retina
/ metabolism
Retinal Pigment Epithelium
/ drug effects
Streptozocin
/ pharmacology
Sulfates
/ metabolism
Vascular Endothelial Growth Factor A
/ metabolism
diabetic retinopathy
hyperglycemia
inflammation
neovascularization
retinal pigment epithelium
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
22 Oct 2021
22 Oct 2021
Historique:
received:
16
09
2021
revised:
10
10
2021
accepted:
12
10
2021
entrez:
13
11
2021
pubmed:
14
11
2021
medline:
12
1
2022
Statut:
epublish
Résumé
(Poly)phenol-derived metabolites are small molecules resulting from (poly)phenol metabolization after ingestion that can be found in circulation. In the last decade, studies on the impact of (poly)phenol properties in health and cellular metabolism accumulated evidence that (poly)phenols are beneficial against human diseases. Diabetic retinopathy (DR) is characterized by inflammation and neovascularization and targeting these is of therapeutic interest. We aimed to study the effect of pyrogallol-
Identifiants
pubmed: 34768833
pii: ijms222111402
doi: 10.3390/ijms222111402
pmc: PMC8583739
pii:
doi:
Substances chimiques
Eye Proteins
0
Nerve Growth Factors
0
Polyphenols
0
Sulfates
0
Vascular Endothelial Growth Factor A
0
vascular endothelial growth factor A, mouse
0
Pyrogallol
01Y4A2QXY0
Streptozocin
5W494URQ81
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fundação para a Ciência e Tecnologia
ID : PD/BD/114251/2016; EXPL-BIM-MEC-1433-2013; PTDC/BTM/ORG/28121/2017
Organisme : iNOVA4Health
ID : UID/Multi/04462/2013
Organisme : European Research Council
ID : European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 804229
Pays : International
Références
Pharmacol Rep. 2012;64(6):1505-14
pubmed: 23406761
Lancet. 2000 Mar 11;355(9207):873-6
pubmed: 10752702
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Eye Vis (Lond). 2015 Sep 30;2:17
pubmed: 26605370
Eur J Nutr. 2019 Feb;58(1):113-130
pubmed: 29151137
J Ocul Pharmacol Ther. 2013 Feb;29(1):33-40
pubmed: 23075401
Endocr Metab Immune Disord Drug Targets. 2020;20(4):599-608
pubmed: 31656158
Mol Nutr Food Res. 2016 Oct;60(10):2130-2140
pubmed: 27242317
Mol Nutr Food Res. 2014 Jul;58(7):1414-25
pubmed: 24740799
Cardiovasc Toxicol. 2019 Apr;19(2):156-167
pubmed: 30302669
J Agric Food Chem. 2007 Nov 28;55(24):9800-4
pubmed: 17973443
Curr Pharm Des. 2018;24(19):2180-2187
pubmed: 29766782
Diabetes Care. 2013 Jun;36(6):1562-8
pubmed: 23275374
Semin Ophthalmol. 2015 Jul;30(4):252-63
pubmed: 24571780
Exp Diabetes Res. 2007;2007:95103
pubmed: 18274606
Mutagenesis. 2012 Nov;27(6):615-21
pubmed: 22952148
J Cell Biochem. 2004 Jun 1;92(3):491-501
pubmed: 15156561
Diabetes Care. 2014;37(1):9-16
pubmed: 24356592
Drug Des Devel Ther. 2018 Jul 03;12:1985-1996
pubmed: 30013318
J Vis Exp. 2011 Aug 12;(54):
pubmed: 21860378
Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1971-80
pubmed: 10845624
Cell Mol Biol (Noisy-le-grand). 2012 Dec 22;58(1):148-52
pubmed: 23273205
Prog Retin Eye Res. 2013 May;34:19-48
pubmed: 23416119
Nutrients. 2019 Apr 02;11(4):
pubmed: 30987058
Exp Eye Res. 2016 Apr;145:450-455
pubmed: 26424220
Molecules. 2014 Aug 13;19(8):12150-72
pubmed: 25123184
Nature. 2011 Apr 21;472(7343):319-24
pubmed: 21389984
Food Chem. 2017 Jan 15;215:274-83
pubmed: 27542476
Food Funct. 2019 Jun 19;10(6):3127-3134
pubmed: 31140506
Mediators Inflamm. 2015;2015:673090
pubmed: 25873768
Surv Ophthalmol. 2002 Dec;47 Suppl 2:S253-62
pubmed: 12507627
Lancet. 2004 Nov 6-12;364(9446):1699-700
pubmed: 15530631
Diabetologia. 2009 Oct;52(10):2027-36
pubmed: 19633827
Int J Mol Sci. 2020 Oct 13;21(20):
pubmed: 33065984
Invest Ophthalmol Vis Sci. 2013 Jan 17;54(1):574-84
pubmed: 23221078
Diabetes Care. 2004 Jan;27 Suppl 1:S84-7
pubmed: 14693935
Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1881-91
pubmed: 23766263
J Nutr Biochem. 2002 Jul;13(7):380-390
pubmed: 12121824
Curr Diabetes Rev. 2006 Feb;2(1):71-98
pubmed: 18220619
Sci Rep. 2017 Sep 13;7(1):11456
pubmed: 28904352
Arch Ophthalmol. 2008 Feb;126(2):227-32
pubmed: 18268214
Diabetes. 2001 Dec;50(12):2641-5
pubmed: 11723044
Mol Vis. 2016 Jul 14;22:761-70
pubmed: 27440994
Br J Nutr. 2015 Feb 14;113(3):454-63
pubmed: 25571923
Am J Clin Nutr. 2013 Nov;98(5):1179-91
pubmed: 24004888
Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2210-8
pubmed: 15914643
J Immunol. 1992 Oct 15;149(8):2736-41
pubmed: 1383325
Invest Ophthalmol Vis Sci. 1995 Apr;36(5):955-64
pubmed: 7706045
Exp Eye Res. 2020 May;194:108027
pubmed: 32259534
Lancet. 2010 Jul 10;376(9735):124-36
pubmed: 20580421